Canara Robeco Bluechip Equity mutual fund review: Worthy bet for the long haul Its portfolio targets two sets of businesses - steady compounders and alpha generators. The tilt is towards proven, quality businesses that provide resilience during market declines
ET Wealth collaborates with Value Research to analyse top mutual funds. We examine the key fundamentals of the fund, its portfolio and performance to help you make an informed investment decision.BASIC FACTS
DATE OF LAUNCH
20 AUGUST 2010
CATEGORY
EQUITY
TYPE
LARGE CAP
AUM*
Rs.8,832 crore
BENCHMARK
S&P BSE 100 TOTAL
RETURN INDEX
WHAT IT COSTS
NAV**
GROWTH OPTION
Rs.43.14
IDCW
Rs.22.04
MINIMUM INVESTMENT
Rs.5,000
MINIMUM SIP AMOUNT
Rs.1,000
EXPENSE RATIO*** (%)
1.86
EXIT LOAD
1% for redemption
within 365 days
*AS ON 30 NOVEMBER 2022
**AS ON 13 DECEMBER 2022
***AS ON 31 OCTOBER 2022
FUND MANAGER
SHRIDATTA BHANDWALDAR
TENURE: 6 YEARS, 4 MONTHS
Recent portfolio changes
New Entrants: Bharat Electronics, Indusind Bank, Indian Hotels Company.
Complete Exits: HDFC Life Insurance Co, Tata Steel, Voltas
Increasing allocation: HDFC Bank, Infosys, Kotak Mahindra Bank, Reliance Inds, SBI Life Insurance, State Bank of India, Sun Pharma, TCS, Indian Hotels Company, Titan Company, Ultratech Cement, United Spirits.
Should you buy?
This large cap fund places strong emphasis on downside protection. Its portfolio targets two sets of businesses - steady compounders and alpha generators. The tilt is towards proven, quality businesses that provide resilience during market declines. This is supplemented with companies that are ripe for earnings turnaround and valuation re-rating. The fund manager remains index conscious but portfolio construction is fairly index agnostic. After consistent showing since 2017, the fund performance has wobbled over the past year. However, the fund manager’s proven capabilities provide comfort for the long haul.
(Source: Value Research)
This story originally appeared on: India Times - Author:Faqs of Insurances
